Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation

被引:35
作者
Casado, Vicent [1 ]
Ferrada, Carla [1 ]
Bonaventura, Jordi [1 ]
Gracia, Eduard [1 ]
Mallol, Josefa [1 ]
Canela, Enric I. [1 ]
Lluis, Carmen [1 ]
Cortes, Antoni [1 ]
Franco, Rafael [1 ]
机构
[1] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Biochem & Mol Biol,Fac Biol, E-08028 Barcelona, Spain
关键词
Adenosine receptors; Dopamine receptors; Competition curves; Two-state dimer receptor model; Equilibrium dissociation constants; Cooperativity; DRUG DISCOVERY; CELL-MEMBRANE; OLIGOMERIZATION; DIMERIZATION; MODEL; HETERODIMERIZATION; COOPERATIVITY; RELEVANCE; AFFINITY; GPCR;
D O I
10.1016/j.bcp.2009.07.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many G-protein-coupled receptors (GPCRs) are expressed on the plasma membrane as dimers. Since drug binding data are currently fitted using equations developed for monomeric receptors, the interpretation of the pharmacological data are equivocal in many cases. As reported here, GPCR dimer models account for changes in competition curve shape as a function of the radioligand concentration used, something that cannot be explained by monomeric receptor models. Macroscopic equilibrium dissociation constants for the agonist and homotropic cooperativity index reflecting the intramolecular communication within the dopamine D-1 or adenosine A(2A) receptor homodimer as well as hybrid equilibrium dissociation constant, which reflects the antagonist/agonist modulation may be calculated by fitting binding data from antagonist/agonist competition experiments to equations developed from dimer receptor models. Comparing fitting the data by assuming a classical monomeric receptor model or a dimer model, it is shown that dimer receptor models provide more clues useful in drug discovery than monomer-based models. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:1456 / 1463
页数:8
相关论文
共 25 条
[1]   Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons [J].
Agnati, LF ;
Ferré, S ;
Lluis, C ;
Franco, R ;
Fuxe, K .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :509-550
[2]   How receptor mosaics decode transmitter signals.: Possible relevance of cooperativity [J].
Agnati, LF ;
Fuxe, K ;
Ferré, S .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (04) :188-193
[3]   Oligomerization of G-protein-coupled transmitter receptors [J].
Bouvier, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (04) :274-286
[4]   Homodimerization of adenosine A2A receptors:: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer [J].
Canals, M ;
Burgueño, J ;
Marcellino, D ;
Cabello, N ;
Canela, EI ;
Mallol, J ;
Agnati, L ;
Ferré, S ;
Bouvier, M ;
Fuxe, K ;
Ciruela, F ;
Lluis, C ;
Franco, R .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (03) :726-734
[5]   Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: The receptor-dimer cooperativity index [J].
Casad, Vincent ;
Cortes, Antoni ;
Ciruela, Francisco ;
Mallol, Josefa ;
Ferre, Sergi ;
Lluis, Carmen ;
Canela, Enric I. ;
Franco, Rafael .
PHARMACOLOGY & THERAPEUTICS, 2007, 116 (03) :343-354
[6]   SOLUBILIZATION OF A1 ADENOSINE RECEPTOR FROM PIG BRAIN - CHARACTERIZATION AND EVIDENCE OF THE ROLE OF THE CELL-MEMBRANE ON THE COEXISTENCE OF HIGH-AFFINITY AND LOW-AFFINITY STATES [J].
CASADO, V ;
CANTI, C ;
MALLOL, J ;
CANELA, EI ;
LLUIS, C ;
FRANCO, R .
JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 26 (04) :461-473
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking [J].
Devi, LA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (10) :532-537
[9]   Principles: A model for the allosteric interactions between ligand binding sites within a dimeric GPCR [J].
Durroux, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (07) :376-384
[10]  
France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15